Skip to main content
. 2022 Feb 24;12:3122. doi: 10.1038/s41598-022-06197-5

Figure 2.

Figure 2

Comparison of RFC2 expression between tumor and normal tissues (left, red represented tumor tissues while blue represented normal tissues) and corresponding immunohistochemistry images in normal tissues (middle) and tumor tissues (right). (AF) The differential expression levels of RFC2 in glioblastoma (GBM) tissues (A), diffuse lower-grade gliomas (LGG) tissues (B), cervical cancer (CESC) tissues (C), colon adenocarcinoma (COAD) tissues (D), liver hepatocellular carcinoma (LIHC) tissues (E), lung squamous cell carcinoma (LUSC) tissues (F), and their corresponding normal tissues were evaluated based on GEPIA and HPA databases. (*P < 0.05).